Achieve Life Sciences
ACHV
15 hedge funds and large institutions have $742K invested in Achieve Life Sciences in 2018 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 2 closing their positions.
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
25% more funds holding
Funds holding: 12 → 15 (+3)
22% more capital invested
Capital invested by funds: $607K → $742K (+$135K)
0% more ownership
Funds ownership: 0.02% → 0.02% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WSCM
Wellington Shields Capital Management
New York
|
+$43.5K |
| 2 |
BBA
BLB&B Advisors
Montgomeryville,
Pennsylvania
|
+$41.2K |
| 3 |
SKK
Shepherd Kaplan Krochuk
Boston,
Massachusetts
|
+$35.2K |
| 4 |
Renaissance Technologies
New York
|
+$31.5K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$21.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$1K |
| 2 |
Fifth Third Bancorp
Cincinnati,
Ohio
|
-$1K |
| 3 |
APA
American Portfolios Advisors
Holbrook,
New York
|
-$1 |
ACHV Hedge Fund Activity: Q1 2018 in Review
15 of the 4,364 institutional investors tracked by Wall St. Rank reported a position in Achieve Life Sciences (ACHV) for Q1 2018, worth a combined $742K — up 22% from $607K a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new ACHV positions and 2 closed out — a net gain of 3 holders — while 5 added to existing stakes and 0 trimmed.
The largest buyer was Wellington Shields Capital Management, opening a new position worth an estimated $43.5K. The largest seller was Citigroup, exiting entirely with an estimated $1K sold.
- 15 institutional investors held Achieve Life Sciences (ACHV) as of Q1 2018, up from 12 in Q4 2017.
- Funds reported $742K of Achieve Life Sciences stock for Q1 2018, up 22% quarter-over-quarter.
- 5 funds opened new Achieve Life Sciences positions in Q1 2018 and 2 closed out, a net change of +3 holders.
- The largest Achieve Life Sciences buyer in Q1 2018 was Wellington Shields Capital Management, an estimated $43.5K added.
- The largest Achieve Life Sciences seller in Q1 2018 was Citigroup, an estimated $1K sold.
Based on aggregated 13F filings for Q1 2018.